AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

A Tailored, Web-based Program (COMPASS) to Improve Exercise and Dietary Changes in Stage I-III Pancreatic Cancer Patients Receiving Neoadjuvant Chemotherapy

RecruitingNAAges 18 Years - anyAllOHSU Knight Cancer Institute
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

This clinical trial studies whether a tailored, web-based program (web portal), Community for Physical Activity and Supportive Nutrition Strategies (COMPASS), can be used to improve exercise and dietary changes in patients with stage I-III pancreatic cancer who are receiving chemotherapy before surgery (neoadjuvant). Pancreatic cancer is a rare and understudied cancer, particularly in the area of promoting a healthy lifestyle to preserve physical and mental well-being during a long and difficult treatment regimen. Since pancreatic cancer is rare, programs have limited resources available to reach the patients who could benefit from programs aimed at promoting exercise and a healthy diet. The COMPASS web-portal is easily accessed by the patient via a computer, tablet, or phone. It is tailored to the unique needs of pancreatic cancer patients and provides exercise and diet recommendations

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: * Age 18 years or older on date of enrollment * Confirmed by review of the date of birth as documented in the electronic medical record (EMR) and subsequently recorded in a case report form (CRF) * Diagnosed with stage I-III pancreatic cancer * Confirmed by EMR review. In cases where the EMR is unclear, their physician will be contacted and asked to confirm * Scheduled to receive neoadjuvant chemotherapy at Oregon Health \& Science University (OHSU) * Confirmed by EMR review. In cases where the EMR is unclear, their physician will be contacted and asked to confirm * Willing to adhere to the study protocol * Confirmed verbally with the participant and response documented in the Participant Tracking database Exclusion Criteria: * Cognitive difficulties that preclude answering the survey questions, participating in the intervention, or giving informed consent * In the event of a suspected undeclared cognitive impairment, it will be confirmed by physician clearance or professional opinion of the Principal Investigators, Dr. Kerri Winters-Stone and/or Dr. Jackilen Shannon * A medical condition, movement or neurological disorder, or medication use that contraindicates participation in light intensity exercise * Confirmed by a combination of reviewing the EMR, and self-report during the initial screening call. If in the professional opinion of the Principal Investigator, Dr. Kerri Winters-Stone or Dr. Jackilen Shannon, contraindications other than those identified by the patient or physician are present, she may consider the participant ineligible * Not fluent in English and therefore incapable of answer survey questions, reading the intervention web portal, and providing informed consent in English * Confirmed verbally with the participant and response documented in the Participant Tracking database
๐Ÿ’Š

What it tests

  • Physical Activity and Nutritional Recommendations and Support
๐Ÿ“

Where

1 site
OHSU Knight Cancer Institute
Portland, United States
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy